Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorNorthwestern University

About this trial

The goal of this observational study is to learn what can predict the return of the sense of smell in patients with chronic rhinosinusitis with nasal polyps being treated with dupilumab. The main questions it aims to answer are:

1. Does obstruction of the olfactory cleft predict return of the sense of smell? 2. Do electrophysiological signals generated by breathing and sniffing behavior predict return of the sense of smell?

Participants starting dupilumab will undergo assessment for their degree of olfactory cleft obstruction, and an electrophysiologic assessment of their olfactory cleft and be followed over 6 months of treatment with dupilumab.

Eligibility criteria

Qualifiers

Well documented history of CRSwNP

BSIT age/sex classified as "abnormal" score

Self-reported stable olfactory deficit of moderate to severe quality > 3 months

Prior endoscopic sinus surgery >3 months, <10 years prior

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Dupilumab - Standard Dose

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators